Mar 11, 2004|
Look closer at performance
The indices have behaved in a very volatile fashion in 2004 with 150-200 points intra-day movements not an uncommon phenomenon. However, the bottomline is that they have failed to head anywhere in the 45 trading sessions of this year so far, which is evident from the fact that the BSE-Sensex has gained a mere 1.4% in 2004 to date. Contrary to this, if we look at the sectoral performance of various indices, the picture is somewhat different. Here we look at some of the sectoral index performances on the BSE and the reasons behind the same. We have considered five indices here i.e. BSE Bankex, BSE FMCG, BSE IT, BSE Healthcare and BSE PSU.
* As on March 10, 2004
Of the above five sectoral indices, while the BSE Bankex (up 5%) and the BSE PSU Index (up 4%) managed to outperform the benchmark index (up 1%), the other three were the laggards, all giving negative returns during the period under consideration (see table above).
The news that favoured the gains in banking stocks in 2004 was the proposal by the government to raise the FDI limit in the banking sector, which ultimately materialised last week with the final nod to raising the FDI limit in banking companies to 74%. This is likely to be a huge positive for the sector in terms of consolidation. However, the caveat here is that while the FDI limits have been raised, the voting rights have been capped at 10% for foreign investors. This means that despite the raising of FDI limits, consolidation may not materialize on a larger scale unless the issue of voting rights is amended. Nevertheless, banking stocks, especially the smaller players in the industry, have been witnessing buying interest on the bourses.
The other key index gaining ground in 2004 is the BSE PSU index, which has gained 4% so far. While PSU stocks remained largely out of favour for most part of the new calendar year, it was only in the last few trading sessions that brought the category back into the reckoning. It must be noted that PSU stocks, especially those who's IPOs were lined up in the month of February and March, had lost considerable ground since the start of the year. With no apparent reason for the weakness in these stocks, one is forced to believe that the divestment minister's indication of a bear cartel responsible for driving the prices down could be the possible reason for the same. This is because, soon after the warning by the minister, the slide in the stocks was controlled. Further, with the successful completion of the offerings, including that of ONGC, the largest amongst all, it seems to have brought faith back into the investors with respect to the government's divestment drive. Also, with the divestment minister indicating the continuance of the divestment programme if it comes back to power, has led to frenzied buying amongst PSU divestment candidates.
Coming to the losers now, the BSE Healthcare index has lost about 5% year-to-date. Apart from the fact that the sector has not witnessed much buying interest right from the beginning of the year, one stock spoiled the picture further for the index. Dr. Reddy's, which has the second highest weightage on the BSE Healthcare Index. It has dragged the healthcare index lower in the recent past. With the Amlodipine Maleate ruling going against the domestic pharma major, the stock received significant drubbing. The reason for the tepid performance of the sector in 2004 can also be attributed to the already rich valuations of the stocks in the sector, which seemed to have factored in some of the optimism related to the post-patent regime from 2005 onwards.
Similar to the pharma sector, the FMCG Index has also given negative returns of 12% in 2004 so far, a large part of which could be attributed to the sell-off witnessed in the HLL stock post the price war that was started by P&G, which slashed the prices of its detergents by 30%-50% forcing the FMCG major to follow. With the highest weightage assigned to this FMCG major in the BSE FMCG Index, any movement in the stock is most likely to have a corresponding movement in the relevant index. Apart from this, the FMCG sector as a whole has been reeling under pressure in recent times owing to reasons like cutthroat competition in the industry (more so from regional players) and the yet to pick up demand from the rural sector owing to the lag effect of good monsoons, which could be seen in the months to come.
Last, but not the least, is the BSE InfoTech sector, which has lost over 14% to date. The only apparent reason for this weak sectoral performance is the increasing opposition to US outsourcing work to countries like India. It must be noted that the industry majors, Infosys (down 12% year to date), Wipro (down 16%), Satyam (down 20%) and HCL Tech (down 10%), constitute over 2/3rd of the total weightage of the BSE InfoTech Index. It must be noted that these companies have been ramping up their employee base since the last few quarters in anticipation of larger volumes. However, the threat from the US outsourcing backlash has also been ever increasing with about 50 Bills already being presented in the US against this trend, clouding the possibilities of higher volumes, at least in the near future, which has led to a re-alignment of the sector valuations.
What we can conclude from the performance of sector specific indices is that from here on, investors should leave behind the expectations that all sectors would rally like that seen in 2003. What we are trying to say here is that from here on investors would have to keenly follow the performance of companies and sectors in order to ascertain the value of the stocks. The 'poor valuations' story may well be over. Growth should be the main consideration from here on as far as assessing the valuations of stocks is concerned.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 18, 2017
Buying the index now will hardly help make money in stocks even in ten years.
Aug 18, 2017
Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.
Aug 17, 2017
PersonalFN simplifies the mutual fund account statement for you.
Aug 17, 2017
A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407